ReviewMolecules (Basel, Switzerland)2026
Intestinal and Blood-Brain Barrier Dysfunction in Lupus: Emerging Mechanisms and Modulation by Cinnamon.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease with evolving pathogenesis. Biological barriers, especially intestinal and blood-brain barriers (BBBs) with their tight junctions (TJ), are gaining attention in recent years as key players in disease initiation and progression. Among natural products targeting these barriers, cinnamon is emerging as a multi-targeted modulator of TJ. This narrative review integrates current evidence about gut and brain barrier dysfunction in lupus pathogenesis and highlights, on the basis of animal studies, the potential of cinnamon as a therapeutic candidate to restore barrier integrity and attenuate immune and neuroinflammation associated with lupus. Experimental evidence from lupus models supports the role of TJ disruption in disease pathogenesis. The alteration of TJ protein distribution in the epithelial barrier is correlated with an increased permeability of the intestinal barrier and changes in the microbiota composition in lupus, with consequent alteration in the gut-liver axis, liver inflammation and oxidative stress. Pre-clinical studies have demonstrated the restorative effect of cinnamon on gut TJ and permeability, microbiota and the gut-liver axis. Moreover, accumulating data suggest BBB disruption in lupus, correlated with neuroinflammation and behavioral disturbances. A murine model demonstrates the protective effect of cinnamon on BBB, especially via TJ localization, with the alleviation of neuropsychiatric alterations. Future perspectives should focus on cinnamon's effect on the gut-brain axis and translational studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.